Ragifilimab (Anti-TNFRSF18 / GITR / CD357)

Synonyms: INCAGN-1876

Ragifilimab (Anti-TNFRSF18 / GITR / CD357) is an anti-human glucocorticoid-induced tumor necrosis factor receptor (tumor necrosis factor superfamily, member 18; TNFRSF18; GITR; CD357) agonistic humanized monoclonal antibody with potential immune checkpoint modulating activity. MW : 145.5 KD.

Ragifilimab (Anti-TNFRSF18 / GITR / CD357)

Purity & Quality Control

Batch: A232701 Purity: 99% Protein concentration: 14.22mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ragifilimab (Anti-TNFRSF18 / GITR / CD357) is an anti-human glucocorticoid-induced tumor necrosis factor receptor (tumor necrosis factor superfamily, member 18; TNFRSF18; GITR; CD357) agonistic humanized monoclonal antibody with potential immune checkpoint modulating activity. MW : 145.5 KD.

Product Details

CAS No. 2207590-51-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ragifilimab (Anti-TNFRSF18 / GITR / CD357) | Ragifilimab (Anti-TNFRSF18 / GITR / CD357) supplier | purchase Ragifilimab (Anti-TNFRSF18 / GITR / CD357) | Ragifilimab (Anti-TNFRSF18 / GITR / CD357) cost | Ragifilimab (Anti-TNFRSF18 / GITR / CD357) manufacturer | order Ragifilimab (Anti-TNFRSF18 / GITR / CD357) | Ragifilimab (Anti-TNFRSF18 / GITR / CD357) distributor